Griphon OL

Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of ACT-293987 in Patients With Pulmonary Arterial Hypertension

Griphon OL [NCT01112306]

Description:  Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of ACT-293987 in Patients With Pulmonary Arterial Hypertension

Drug: ACT-293987

Primary Investigator: Engel

Drug/Device Information
ACT-293987 (non-prostanoid prostacyclin agonist)
Long term open label
Actelion
Major Inclusion and Exclusion
Meet one of the following:
Completed Griphon 1
Experienced a clinical worsening of PAH during Griphon 1